Literature DB >> 26745491

Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.

Bin Ren1,2, Zheng-Shan Zhang2, Wei-Wei Liu3, Xiang-Yang Bao2, De-Sheng Li2, Cong Han2, Peng Xian2, Feng Zhao2, Hui Wang2, Hai Wang1, Lian Duan2.   

Abstract

OBJECTIVE Debate exists regarding the merits and shortcomings of an indirect bypass procedure for treating adult patients with moyamoya disease (MMD). Considerable variation in neovascularization occurs among different organs in patients with diabetes mellitus. Here, the effect of encephaloduroarteriosynangiosis on MMD associated with Type 2 diabetes mellitus (T2DM) is evaluated. METHODS A retrospective and 1:2 matched case-control study was conducted in moyamoya patients with or without T2DM (n = 180). Postoperative collateral formations were graded according to the Modified Collateral Grading System that originated from the Matsushima Angiographic Stage Classification. Neurological function outcomes before and after the operation were evaluated according to the modified Rankin Scale. Univariate and multivariate logistic regression analyses were performed to determine the risk factors for clinical outcome. RESULTS There was no statistically significant difference in the constituent ratios of initial symptom and preoperative Suzuki stage between patients with and without T2DM. Progression of angiopathy around the circle of Willis was postoperatively observed in bilateral internal carotid arteries in both groups. Patients with T2DM had a higher postoperative Suzuki stage (p < 0.01) and more frequent development of collateral angiogenesis germinating from the external carotid after indirect revascularization procedures in the surgical cerebral hemisphere (82.7% vs 72.2%; p < 0.05). The extent of postoperative collateral formation in patients with diabetes mellitus was significantly higher (p < 0.01). Postoperative clinical improvement in the diabetes group was more common after revascularization procedures (p < 0.05), and the diabetes group had lower modified Rankin Scale scores (p < 0.05) in comparison with the nondiabetes group. Late postoperative stroke and posterior cerebral artery involvement were identified as predictors of unfavorable clinical outcome in both groups, while T2DM was associated with a favorable clinical outcome. CONCLUSIONS Encephaloduroarteriosynangiosis is an efficacious treatment for adult patients with MMD. Patients with T2DM could achieve better collateral circulation and clinical improvement following surgery.

Entities:  

Keywords:  CBF = cerebral blood flow; DM = diabetes mellitus; EDAS = encephaloduroarteriosynangiosis; MCA = middle cerebral artery; MMD = moyamoya disease; PCA = posterior cerebral artery; STA = superficial temporal artery; T2DM = Type 2 DM; Type 2 diabetes; clinical outcome; collaterals; mRS = modified Rankin Scale; moyamoya disease; revascularization; vascular disorders

Mesh:

Year:  2016        PMID: 26745491     DOI: 10.3171/2015.7.JNS15218

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

Review 1.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

2.  Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Authors:  Xiang Guo; Xuexia Yuan; Lingyun Gao; Yueqin Chen; Hao Yu; Weijian Chen; Yunjun Yang; Zhen Chong; Zhanguo Sun; Feng Jin; Deguo Liu
Journal:  Eur Radiol       Date:  2021-05-06       Impact factor: 5.315

3.  Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China.

Authors:  Fei Ye; Tianzhu Wang; Haoyuan Yin; Jiaoxing Li; Haiyan Li; Tongli Guo; Xiong Zhang; Tingting Yang; Liang Jie; Xiaoxin Wu; Qi Li; Wenli Sheng
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

4.  Moyamoya syndrome with ruptured aneurysm in α-thalassemia: A case report.

Authors:  Jiabin Zhu; Mingwen Zhang; Yichun Sun; Xiaofeng Zhang
Journal:  Exp Ther Med       Date:  2022-07-05       Impact factor: 2.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.